Indivior signs deal to sell schizophrenia drug in Canada
May 09, 2019 at 07:12 AM EDT
British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.
